The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model

Journal of Pediatric Surgery

Volumn 45, Issue 5, 2010, Pages 987-995

  Taqi, Esmaeel ^a   Wallace, Laurie E ^a   de Heuvel, Elaine ^a   Chelikani, Prasanth K ^a   Zheng, Huiyuan ^b   Berthoud, Hans Rudolph ^b   Holst, Jens J ^c   Sigalet, David L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

bFGF; Crypt cell proliferation; EGF; Gastric Roux en Y bypass model; GLP 2; IGF 1; KGF; SGLT 1; Short bowel syndrome

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 2; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 5; KERATINOCYTE GROWTH FACTOR; PEPTIDE YY; SODIUM GLUCOSE COTRANSPORTER 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT BYPASS; BOWEL WIDTH; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; EXPERIMENTAL SURGERY; GASTRIC ROUX EN Y BYPASS; HORMONE BLOOD LEVEL; INTESTINE ADAPTATION; INTESTINE VILLUS; MALE; MORPHOLOGY; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH BYPASS; WEIGHT REDUCTION;

ADAPTATION, PHYSIOLOGICAL; ANASTOMOSIS, ROUX-EN-Y; ANIMALS; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 7; GLUCAGON-LIKE PEPTIDE 2; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SHORT BOWEL SYNDROME; SODIUM-GLUCOSE TRANSPORTER 1;

EID: 77951653574     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.02.036     Document Type: Article

References (50)

1. Rickham P.P. Massive small intestinal resection in newborn infants. Hunterian Lecture delivered at the Royal College of Surgeons of England on 13th April 1967. Ann R Coll Surg Engl 41 (1967) 480-492
2. Sigalet D.L. Short bowel syndrome in infants and children: an overview. Semin Pediatr Surg 10 (2001) 49-55
3. Vanderhoof J.A. Short bowel syndrome in children. Curr Opin Pediatr 7 (1995) 560-568
4. Quiros-Tejeira R.E., Ament M.E., Reyen L., et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 145 (2004) 157-163
5. Wales P.W., de Silva N., Kim J., et al. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg 39 (2004) 690-695
6. Sigalet D., Boctor D., Robertson M., et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 19 (2009) 1-6
7. Wales P.W., de Silva N., Kim J.H., et al. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 40 (2005) 755-762
8. Dowling R.H., and Booth C.C. Functional compensation after small-bowel resection in man. Demonstration by direct measurement. Lancet 2 (1966) 146-147
9. Williamson R.C. Intestinal adaptation (first of two parts). Structural, functional and cytokinetic changes. N Engl J Med 298 (1978) 1393-1402
10. Spencer A.U., Kovacevich D., Kinney-Barnett M., et al. Pediatric short-bowel syndrome: the cost of comprehensive care. Am J Clin Nutr 88 (2008) 1552-1559
11. Utter S., and Duggan C. Short bowel syndrome (2000), Decker, Hamilton
12. Martin G.R., Wallace L.E., and Sigalet D.L. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 286 (2004) G964-G972
13. Tappenden K.A. Mechanisms of enteral nutrient-enhanced intestinal adaptation. Gastroenterology 130 (2006) S93-S99
14. Sukhotnik I., Mor-Vaknin N., Drongowski R.A., et al. Effect of dietary fat on fat absorption and concomitant plasma and tissue fat composition in a rat model of short bowel syndrome. Pediatr Surg Int 20 (2004) 185-191
15. Vanderhoof J.A., Park J.H., Herrington M.K., et al. Effects of dietary menhaden oil on mucosal adaptation after small bowel resection in rats. Gastroenterology 106 (1994) 94-99
16. Bines J., Francis D., and Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 26 (1998) 123-128
17. Vanderhoof J.A., Grandjean C.J., Burkley K.T., et al. Effect of casein versus casein hydrolysate on mucosal adaptation following massive bowel resection in infant rats. J Pediatr Gastroenterol Nutr 3 (1984) 262-267
18. Weser E., Babbitt J., Hoban M., et al. Intestinal adaptation. Different growth responses to disaccharides compared with monosaccharides in rat small bowel. Gastroenterology 91 (1986) 1521-1527
19. Kollman K.A., Lien E.L., and Vanderhoof J.A. Dietary lipids influence intestinal adaptation after massive bowel resection. J Pediatr Gastroenterol Nutr 28 (1999) 41-45
20. Ulshen M.H., and Herbst C.A. Effect of removal of pancreaticobiliary secretions on adaptation to short bowel in orally nourished rats. Am J Clin Nutr 39 (1984) 762-770
21. Sigalet D.L., and Martin G.R. Mechanisms underlying intestinal adaptation after massive intestinal resection in the rat. J Pediatr Surg 33 (1998) 889-892
22. Barnard J.A., Beauchamp R.D., Russell W.E., et al. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 108 (1995) 564-580
23. Jeppesen P.B., Sanguinetti E.L., Buchman A., et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54 (2005) 1224-1231
24. Ulshen M.H., Dowling R.H., Fuller C.R., et al. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Gastroenterology 104 (1993) 973-980
25. Ohneda K., Ulshen M.H., Fuller C.R., et al. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology 112 (1997) 444-454
26. Drucker D.J., DeForest L., and Brubaker P.L. Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2. Am J Physiol 273 (1997) G1252-G1262
27. Houchen C.W., George R.J., Sturmoski M.A., et al. FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol 276 (1999) G249-G258
28. Geske M.J., Zhang X., Patel K.K., et al. FGF9 signaling regulates small intestinal elongation and mesenchymal development. Development 135 (2008) 2959-2968
29. Falcone Jr. R.A., Stern L.E., Kemp C.J., et al. Intestinal adaptation occurs independent of transforming growth factor-alpha. J Pediatr Surg 35 (2000) 365-370
30. Helmrath M.A., Shin C.E., Erwin C.R., et al. The EGF\EGF-receptor axis modulates enterocyte apoptosis during intestinal adaptation. J Surg Res 77 (1998) 17-22
31. Sigalet D.L., Martin G.R., Butzner J.D., et al. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg 40 (2005) 763-768
32. Housley R.M., Morris C.F., Boyle W., et al. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 94 (1994) 1764-1777
33. Johnson W.F., DiPalma C.R., Ziegler T.R., et al. Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome. Vet Surg 29 (2000) 17-27
34. Gornacz G.E., Ghatei M.A., Al-Mukhtar M.Y., et al. Plasma enteroglucagon and CCK levels and cell proliferation in defunctioned small bowel in the rat. Dig Dis Sci 29 (1984) 1041-1049
35. Zheng H., Shin A.C., Lenard N.R., et al. Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol 297 (2009) R1273-R1282
36. Amin H., Holst J.J., Hartmann B., et al. Functional ontogeny of the proglucagon derived peptide axis in human neonates. Pediatrics 121 (2008) e180-e186
37. Hartmann B., Harr M.B., Jeppesen P.B., et al. In vivo and in vitro degradation of glucagon-like peptide-2 in humans. J Clin Endocrinol Metab 85 (2000) 2884-2888
38. Hartmann B., Johnsen A.H., Orskov C., et al. Structure, measurement, and secretion of human glucagon-like peptide-2. Peptides 21 (2000) 73-80
39. Kaji T., Tanaka H., Holst J.J., et al. The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat. Eur J Pharmacol 596 (2008) 138-145
40. Sigalet D.L., Wallace L.E., Holst J.J., et al. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol 293 (2007) G211-G221
41. Martin G.R., Wallace L.E., Hartmann B., et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 288 (2005) G431-G438
42. Dube P.E., Forse C.L., Bahrami J., et al. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology 131 (2006) 589-605
43. Dube P.E., Rowland K.J., and Brubaker P.L. Glucagon-like peptide-2 activates {beta}-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-1. Endocrinology 149 (2008) E291-E301
44. Gospodarowicz D., Ferrara N., Schweigerer L., et al. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8 (1987) 95-114
45. Orskov C., Hartmann B., Poulsen S.S., et al. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept 124 (2005) 105-112
46. Warner B.W., and Erwin C.R. Critical roles for EGF receptor signaling during resection-induced intestinal adaptation. J Pediatr Gastroenterol Nutr 43 Suppl 1 (2006) S68-S73
47. Washizawa N., Gu L.H., Gu L., et al. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats. JPEN JPEM J Parenter Enteral Nutr 28 (2004) 399-409
48. Kaji T., Tanaka H., Redstone H., et al. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection. J Surg Res 152 (2009) 271-280
49. Whang E.E., Dunn J.C., Joffe H., et al. Enterocyte functional adaptation following intestinal resection. J Surg Res 60 (1996) 370-374
50. Nadreau E., Baraboi E.D., Samson P., et al. Effects of the biliopancreatic diversion on energy balance in the rat. Int J Obes (Lond) 30 (2006) 419-429